Cover Image
Market Research Report
Product code 
999709

H1N1 Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Published: | IMARC Services Private Limited | 111 Pages | Delivery time: 2-3 business days

Price

Back to Top
H1N1 Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026
Published: May 20, 2021
IMARC Services Private Limited
Content info: 111 Pages
Delivery time: 2-3 business days
  • ALL
  • Description
  • Table of Contents
Description

The global H1N1 vaccines market reached a value of US$ 1.8 Billion in 2020. Looking forward, IMARC Group expects the market to exhibit moderate growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors. These insights are included in the report as a major market contributor.

The H1N1 virus is an infectious disease characterized by a persistent cough, high fever, red-watery eyes, body aches and headache. The illness is known to have a detrimental effect on the existing chronic ailments, such as Pneumonia, Chronic Obstructive Pulmonary Disease (COPD) and Bronchitis, and can be fatal in severe cases. H1N1 vaccines are a preventive measure administered through intradermal and intranasal procedures to provide active immunization against the virus.

Increasing incidences of epidemic H1N1 infection and declining immunity of the general population are among the key factors driving the market growth. With increasing age, the risk of developing respiratory tract diseases and immunodeficiency disorders also escalates, thereby increasing the risk of acquiring the H1N1 flu infection. However, extensive research and development in the field of immunology and vaccine technologies coupled with extensive support from global health organizations are expected to promote the distribution of quality vaccines. Moreover, a number of developed countries such as Australia, the United Kingdom, and the United States have also included H1N1 vaccinations under their National Immunization Program (NIP) that has increased the demand for these vaccines. Additionally, technological advancements coupled with a rising awareness amongst patients about preventive methods has also led to a heightened demand for H1N1 vaccines.

IMARC Group's latest report provides a deep insight into the global H1N1 vaccines market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global H1N1 vaccines industry in any manner.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global H1N1 vaccines market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, vaccine type, key brands and market type.
  • Breakup by Vaccine Type
  • Intramuscular
  • Intranasal
  • Intradermal

Breakup by Market Type:

  • Public
  • Private

Analysis of Key Brands:

  • Agripal
  • Fiuarix
  • Influgen
  • Influvac
  • Nasovac
  • Vaxigrip
  • Others

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market along with the profiles of the key players.

Key Questions Answered in This Report:

  • How has the global H1N1 vaccines market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global H1N1 vaccines industry?
  • What are the popular vaccines type?
  • What are the major market types?
  • What are the various stages in the value chain of the global H1N1 vaccines industry?
  • What are the key driving factors and challenges in the global H1N1 vaccines market?
  • What is the structure of the global H1N1 vaccines industry and who are the key players?
  • What is the degree of competition in the industry?
  • What are the profit margins in the industry?
Table of Contents
Product Code: SR1020C75_Report

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global H1N1 Vaccines Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Breakup by Vaccines Type
  • 5.5 Breakup by Market Type
  • 5.6 Analysis of Key Brands
  • 5.7 Breakup by Region
  • 5.8 Market Forecast

6 Market Breakup by Vaccines Type

  • 6.1 Intramuscular
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Intranasal
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Intradermal
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Type

  • 7.1 Public
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Private
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Europe
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Asia Pacific
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Middle East and Africa
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Latin America
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Analysis of Key Brand

  • 9.1 Agripal
  • 9.2 Fiuarix
  • 9.3 Influgen
  • 9.4 Influvac
  • 9.5 Nasovac
  • 9.6 Vaxigrip
  • 9.7 Others

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

  • 13.1 Price Indicators
  • 13.2 Price Structure
  • 13.3 Margin Analysis

14 Industry Developments

  • 14.1 Pipeline and New Product Launches
  • 14.2 Mergers & Acquisitions and Partnerships

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players

List of Figures

  • Figure 1: Global: H1N1 Vaccines Market: Major Drivers and Challenges
  • Figure 2: Global: H1N1 Vaccines Market: Sales Value (in Billion US$), 2015 - 2020
  • Figure 3: Global: H1N1 Vaccines Market: Breakup by Vaccines Type (in %), 2020
  • Figure 4: Global: H1N1 Vaccines Market: Breakup by Type (in %), 2020
  • Figure 5: Global: H1N1 Vaccines Market: Breakup by Region (in %), 2020
  • Figure 6: Global: H1N1 Vaccines Industry: SWOT Analysis
  • Figure 7: Global: H1N1 Vaccines Industry: Value Chain Analysis
  • Figure 8: Global: H1N1 Vaccines Industry: Porter's Five Forces Analysis
  • Figure 9: Global: H1N1 Vaccines Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 10: Global: H1N1 Vaccines (Intramuscular) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 11: Global: H1N1 Vaccines (Intramuscular) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 12: Global: H1N1 Vaccines (Intranasal) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 13: Global: H1N1 Vaccines (Intranasal) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 14: Global: H1N1 Vaccines (Intradermal) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 15: Global: H1 N1 Vaccines (Intradermal) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 16: Global: H1N1 Vaccines (Public) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 17: Global: H1N1 Vaccines (Public) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 18: Global: H1N1 Vaccines (Private) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 19: Global: H1N1 Vaccines (Private) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 20: North America: H1N1 Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 21: North America: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 22: Europe: H1N1 Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 23: Europe: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 24: Asia Pacific: H1N1 Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 25: Asia Pacific: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 26: Middle East and Africa: H1N1 Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 27: Middle East and Africa: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 28: Latin America: H1N1 Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 29: Latin America: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026

List of Tables

  • Table 1: Global: H1N1 Vaccines Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: H1N1 Vaccines Market Forecast: Breakup by Vaccines Type (in Million US$), 2021-2026
  • Table 3: Global: H1N1 Vaccines Market Forecast: Breakup by Type (in Million US$), 2021-2026
  • Table 4: Global: H1N1 Vaccines Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 5: Global: H1N1 Vaccines Market Structure
  • Table 6: Global: H1N1 Vaccines Market: Key Players